Business

Atlas Cloud Announces Grant of Options

Atlas Cloud Announces Grant of Options.

articleIsracann Biosciences Inc.June 22, 20185/company/isracann-biosciences-inc/news/atlas-cloud-announces-grant-of-options
Atlas Cloud Announces Grant of Options

About this update from Isracann Biosciences Inc.

[{"type":"text","content":"\nVANCOUVER, British Columbia, June 22, 2018 (GLOBE NEWSWIRE) -- Atlas Cloud Enterprises Inc. (CSE:AKE) (XFRA:A49) (OTCPINK:ATLEF) (the “Company” or “Atlas Cloud”), an experienced IT service provider focused on becoming the lowest cost producer in the blockchain and digital currency mining sector, is pleased to announce that it has granted 6,125,000 incentive stock options under the Company’s stock option plan to certain officers, directors, and consultants effective June 21, 2018. The Options are exercisable at a price of $0.40 for a period of 5 years from the date of grant.\n About Atlas Cloud Enterprises Inc.Atlas Cloud Enterprises Inc. is a growth oriented, CSE-listed company focusing on the business of providing co-location and backup/redundancy IT, telecom equipment and cloud computing. Atlas Cloud will provide customers with secure power access, cooling and bandwidth to ensure co-located, back-up or Cloud systems offer minimum risk of failure. Furthermore, Atlas is focused on the blockchain sector and digital currency mining. Atlas Cloud aims to become the lowest-cost producer of digital currency mining and blockchain infrastructure. Atlas Cloud owns a facility currently undergoing preparations for use as a digital currency mining operation located in Electric City, WA. This location currently benefits from a dedicated low-cost energy source of 5.0 MW and the Company is seeking to significantly expand its operations with the development of additional facilities offering economical, high-yield energy infrastructure opportunities. On behalf of the Board, “Charlie Kiser” Charlie Kiser, Chief Executive Officer Contact Atlas Cloud Investor Relations+1(604) 343-8661 [email protected] www.atlascloud.ca The CSE does not accept responsibility for the adequacy or accuracy of this release. Forward Looking InformationCertain information set forth in this news release may contain forward-looking statements that involve substantial known and unknown risks and uncertainties. These forward-looking statements are subject to numerous risks and uncertainties, certain of which are beyond the control of the Company, including but not limited to, the future business operations of Atlas Cloud. Readers are cautioned that the assumptions used in the preparation of such information, although consider...

More updates from Isracann Biosciences Inc.